Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stereotaxis (STXS)
NYSE MKT:STXS
Holding STXS?
Track your performance easily
STXS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $3.29
Previous Close$2.11
Volume936.05K
Average Volume (3M)325.58K
Market Cap
$178.62M
Enterprise Value$169.22M
Total Cash (Recent Filing)$14.68M
Total Debt (Recent Filing)$5.28M
Price to Earnings (P/E)―
Beta1.26
Next Earnings
Nov 07, 2024EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding84,656,254
10 Day Avg. Volume266,415
30 Day Avg. Volume325,581
Standard Deviation0.18
R-Squared0.19
Alpha-0.00512
Financial Highlights & Ratios
Price to Book (P/B)16.23
Price to Sales (P/S)7.52
Price to Cash Flow (P/CF)-14.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.13
Enterprise Value/Gross Profit11.39
Enterprise Value/Ebitda-8.00
Forecast
1Y Price Target
$4.50Price Target Upside113.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Stereotaxis News
Bulls Say, Bears Say
Bulls Say
Product InnovationStereotaxis is transforming its endovascular robotic offering with the addition of a new robot (GenesisX), new disposable (MAGiC), and platform optionality (new indications).
Regulatory ApprovalsSTXS received CE Mark approval in Europe for GenesisX, filed a 510(k) for the system and made progress with the EU and US regulatory reviews of its MAGiC catheter.
Revenue GrowthThe new product portfolio enables increased per-procedure revenue potential (3-5x current per procedure potential), reduces system adoption friction, and establishes a platform technology.
Bears Say
Financial PerformanceQ2 revenue of $4.5M was short of the Street at $5.6M on continued unpredictability in order recognition due to construction timelines.
RevenueRevenue totaled $4.5M, down from $7.9M in the prior-year period and short of the Street's $5.6M consensus estimate.
Revenue OutlookStereotaxis now expects revenue to be greater than $14.0M in 2H24, implying total revenue for 2024 to be down -5% Y/Y.
---
Ownership Overview
45.04% Insiders
5.27% Mutual Funds
39.91% Other Institutional Investors
9.78% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STXS FAQ
What was Stereotaxis’s price range in the past 12 months?
Stereotaxis lowest stock price was $1.40 and its highest was $3.29 in the past 12 months.
What is Stereotaxis’s market cap?
Currently, no data Available
When is Stereotaxis’s upcoming earnings report date?
Stereotaxis’s upcoming earnings report date is Nov 07, 2024 which is in 43 days.
How were Stereotaxis’s earnings last quarter?
Stereotaxis released its earnings results on Aug 12, 2024. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of -$0.052 by -$0.018.
Is Stereotaxis overvalued?
According to Wall Street analysts Stereotaxis’s price is currently Undervalued.
Does Stereotaxis pay dividends?
Stereotaxis does not currently pay dividends.
What is Stereotaxis’s EPS estimate?
Stereotaxis’s EPS estimate is -$0.05.
How many shares outstanding does Stereotaxis have?
Stereotaxis has 84,656,260 shares outstanding.
What happened to Stereotaxis’s price movement after its last earnings report?
Stereotaxis reported an EPS of -$0.07 in its last earnings report, missing expectations of -$0.052. Following the earnings report the stock price went up 11.667%.
Which hedge fund is a major shareholder of Stereotaxis?
Among the largest hedge funds holding Stereotaxis’s share is GMT Capital Corp. It holds Stereotaxis’s shares valued at 230K.
---
Stereotaxis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.50 (113.27% Upside)
$4.50 (113.27% Upside)
Blogger Sentiment
Bullish
STXS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 126.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $17.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 5.6%
Last 30 Days ▲ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
19.20%
12-Months-Change
Fundamentals
Return on Equity
-94.89%
Trailing 12-Months
Asset Growth
-25.46%
Trailing 12-Months
Company Description
Stereotaxis
Stereotaxis, Inc. engages in the design, manufacture, and market of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. Its products include The Epoch Solution, Niobe Magnetic Navigation System, Vdrive Robotic Navigation System, and Odyssey Solution. The company was founded in June 1990 and is headquartered in St. Louis, MO.
---
STXS Earnings Call
Q2 2024
0:00 / 0:00
---
STXS Stock 12 Month Forecast
Average Price Target
$4.50
▲(113.27% Upside)
Technical Analysis
Best Analysts Covering STXS
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+2.84%
assigned a buy rating 7 months ago
Copying Alexander Nowak's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +2.84% per trade.
---